Australia's most trusted
source of pharma news
Tuesday, 21 January 2025
Posted 23 December 2024 AM
In closing out 2023, we were bold enough to predict that Covid would continue to fade while obesity drugs would be the big preoccupation of 2024.
Although Covid is still with us and will probably always be, it has indeed moved further into the background while, as predicted, obesity has taken centre stage. Well, sort of. Some might argue the actual treatments are still in the wings.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.